Home/Filings/4/0001104659-23-068974
4//SEC Filing

Deflin Gayle 4

Accession 0001104659-23-068974

CIK 0001297184other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:18 PM ET

Size

6.9 KB

Accession

0001104659-23-068974

Insider Transaction Report

Form 4
Period: 2023-06-05
Deflin Gayle
Director
Transactions
  • Award

    Common Stock

    2023-06-05+2,7166,879 total
  • Award

    Stock Option (right to buy)

    2023-06-05+7,0167,016 total
    Exercise: $46.01Exp: 2031-06-05Common Stock (7,016 underlying)
Footnotes (2)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 5, 2024.
  • [F2]All of the shares subject to the option vest on June 5, 2024.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001866024

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:18 PM ET
Size
6.9 KB